Cairo - Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) reported a rise in profits in the first quarter of 2017 by 29% year-on-year, as shown by the company’s financial statements.
The company said in a statement to the Egyptian Exchange (EGX) on Monday that profits totalled EGP 150.5 million in the three-month period that ended on 31 March compared to EGP 116.6 million in Q1-16.
